-
2561
Educational effectiveness of cognitive and metacognitive strategies on educational self-destructive behaviors and negative self-evaluation thinking in Arabic lessons
Published 2024-09-01“…Extended abstract Introduction Researchers tested many human needs and motivations and thus new theories were proposed, one of whom is the theory of documents. According to this theory, when faced with others, people try to attribute failure to external factors such as luck and task difficulty; and success to internal factors such as talent and ability. …”
Get full text
Article -
2562
COVID-19 Induced Cardiomyopathy Successfully Treated with Tocilizumab
Published 2022-01-01Get full text
Article -
2563
An integrated strength-carbon emissions-total cost model for silica fume concrete
Published 2025-07-01Get full text
Article -
2564
-
2565
Method and Validation of Real‐Time Global Ionosphere Modeling Constraint by Multi‐Source GNSS/LEO Data
Published 2024-04-01“…The corresponding RMS values are 1.19, 1.15, and 1.57 TECU.…”
Get full text
Article -
2566
Efficacy and Safety of Murivenna Anal Infiltration Compared to Diltiazem Topical Application in Chronic Anal Fissure: Protocol for a Prospective, Randomized, Open-Label Clinical Tr...
Published 2025-02-01“…Trial RegistrationClinical Trials Registry India CTRI/2023/09/057330; https://tinyurl.com/y4ut9e8p International Registered Report Identifier (IRRID)DERR1-10.2196/63063…”
Get full text
Article -
2567
-
2568
-
2569
-
2570
Systematic review of spontaneous reports of myocarditis and pericarditis in transplant recipients and immunocompromised patients following COVID-19 mRNA vaccination
Published 2022-07-01“…Most reports followed a second vaccine dose and occurred within 14 days. The frequency of reporting was similar to the wider population (PRR=1.36 (95% CI=0.89 to 1.82) for VAERS population).Conclusions Myocarditis and pericarditis following COVID-19 vaccination are very rare, and benefits of COVID-19 vaccination continue to outweigh any perceived risks. …”
Get full text
Article -
2571
Uso e ocupação do solo em São Paulo, alterações climáticas e os riscos ambientais contemporâneos
Published 2018-03-01“…From analysis of data provinient from two stations located in São Paulo (Santana and Ipiranga) we can observe that there were changes in the climate in São Paulo in recent decades, like the increase of the temperature and the number of days with precipitation > of 30mm and 50mm, in addition to decreasing relative humidity of the air. …”
Get full text
Article -
2572
Vaginal progesterone as luteal phase support in natural cycle frozen-thawed embryo transfer (ProFET): protocol for a multicentre, open-label, randomised controlled trial
Published 2022-07-01“…Participants are randomised (1:1:1) to either luteal phase progesterone for 3 weeks, luteal phase progesterone for 7 weeks or no luteal phase progesterone. …”
Get full text
Article -
2573
Dog Bite Injuries: Primary and Secondary Emergency Department Presentations—A Retrospective Cohort Study
Published 2013-01-01Get full text
Article -
2574
Fatal Retroperitoneal Bleeding Caused by Neurofibromatosis: A Case Report and Review of the Literature
Published 2015-01-01“…Unfortunately, the patient died five days later due to irreversible brain damage. Revision of an MRI scan made one year earlier showed a 10 cm large retroperitoneal neurofibromatous lesion exactly at the location of the current bleeding. …”
Get full text
Article -
2575
-
2576
Risk of infection and conversion time from external to definitive fixation in open tibial fracture
Published 2024-12-01“…Abstract Background An open fracture of the tibia is one of the most common and dangerous type of open fractures. …”
Get full text
Article -
2577
-
2578
The formula for Peace as a result of a future without war in Ukraine
Published 2025-01-01Get full text
Article -
2579
-
2580
Efficacy and Safety of Ergoferon in Children from 6 Months to 6 Years Old with Acute Respiratory Viral Infections in Contemporary Outpatient Practice: A Multicenter, Double-Blind,...
Published 2021-01-01“…Compared to placebo, Ergoferon reduced time to alleviation of all ARI symptoms (4.5 ± 1.7 versus 5.2 ± 2.2 days in placebo; p=0.026) including fever (2.8 ± 1.5 vs 3.4 ± 2.0; p=0.031), flu-like nonspecific (4.0 ± 1.8 vs 4.7 ± 2.2, p=0.022), and nasal/throat/chest (4.3 ± 2.0 versus 5.0 ± 2.3; p=0.024) symptoms. …”
Get full text
Article